Literature DB >> 33781934

Scoring tool for systemic symptoms during aspirin challenge detects mediator production in aspirin-exacerbated respiratory disease.

Patrick J Staso1, Pingsheng Wu1, Tanya M Laidlaw2, Katherine N Cahill3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33781934      PMCID： PMC8222107          DOI： 10.1016/j.anai.2021.03.025

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.248


× No keyword cloud information.
  10 in total

1.  Effect of LTRA in L-ASA Challenge for Aspirin-Exacerbated Respiratory Disease Diagnosis.

Authors:  Fernando Ramírez-Jiménez; Andrea Vázquez-Corona; Paulina Sánchez-de la Vega Reynoso; Gandhi F Pavón-Romero; Marco Alejandro Jiménez-Chobillon; Armando Roberto Castorena-Maldonado; Luis M Teran
Journal:  J Allergy Clin Immunol Pract       Date:  2020-11-04

2.  Sinus Surgery Is Associated with a Decrease in Aspirin-Induced Reaction Severity in Patients with Aspirin Exacerbated Respiratory Disease.

Authors:  Elina Jerschow; Matthew L Edin; Yuling Chi; Beth Hurst; Waleed M Abuzeid; Nadeem A Akbar; Marc Gibber; Marvin P Fried; Weiguo Han; Teresa Pelletier; Zhen Ren; Taha Keskin; Gigia Roizen; Fred B Lih; Artiom Gruzdev; J Alyce Bradbury; Victor Schuster; Simon Spivack; David Rosenstreich; Darryl C Zeldin
Journal:  J Allergy Clin Immunol Pract       Date:  2018-12-21

3.  Use of a composite symptom score during challenge in patients with suspected aspirin-exacerbated respiratory disease.

Authors:  Kevin A Cook; Brian D Modena; Nathan E Wineinger; Katharine M Woessner; Ronald A Simon; Andrew A White
Journal:  Ann Allergy Asthma Immunol       Date:  2017-05       Impact factor: 6.347

4.  Sinus surgery improves lower respiratory tract reactivity during aspirin desensitization for AERD.

Authors:  George X Huang; Marina L Palumbo; Joseph I Singer; Katherine N Cahill; Tanya M Laidlaw
Journal:  J Allergy Clin Immunol Pract       Date:  2019-03-12

5.  Prostaglandin D₂: a dominant mediator of aspirin-exacerbated respiratory disease.

Authors:  Katherine N Cahill; Jillian C Bensko; Joshua A Boyce; Tanya M Laidlaw
Journal:  J Allergy Clin Immunol       Date:  2014-09-11       Impact factor: 10.793

6.  Plasma tryptase elevation during aspirin-induced reactions in aspirin-exacerbated respiratory disease.

Authors:  Katherine N Cahill; Katherine Murphy; Joseph Singer; Elliot Israel; Joshua A Boyce; Tanya M Laidlaw
Journal:  J Allergy Clin Immunol       Date:  2018-10-16       Impact factor: 10.793

7.  Unique Effect of Aspirin Therapy on Biomarkers in Aspirin-exacerbated Respiratory Disease. A Prospective Trial.

Authors:  Katherine N Cahill; Jing Cui; Parul Kothari; Katherine Murphy; Benjamin A Raby; Joseph Singer; Elliot Israel; Joshua A Boyce; Tanya M Laidlaw
Journal:  Am J Respir Crit Care Med       Date:  2019-09-15       Impact factor: 21.405

8.  Inflammatory heterogeneity in aspirin-exacerbated respiratory disease.

Authors:  William C Scott; Katherine N Cahill; Ginger L Milne; Ping Li; Quanhu Sheng; Li Ching Huang; Spencer Dennis; Jacob Snyder; Ashley M Bauer; Rakesh K Chandra; Naweed I Chowdhury; Justin H Turner
Journal:  J Allergy Clin Immunol       Date:  2020-11-12       Impact factor: 10.793

Review 9.  The role of aspirin desensitization followed by oral aspirin therapy in managing patients with aspirin-exacerbated respiratory disease: A Work Group Report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of Allergy, Asthma & Immunology.

Authors:  Whitney W Stevens; Elina Jerschow; Alan P Baptist; Larry Borish; John V Bosso; Kathleen M Buchheit; Katherine N Cahill; Paloma Campo; Seong H Cho; Anjeni Keswani; Joshua M Levy; Anil Nanda; Tanya M Laidlaw; Andrew A White
Journal:  J Allergy Clin Immunol       Date:  2020-12-09       Impact factor: 10.793

10.  A trial of type 12 purinergic (P2Y12) receptor inhibition with prasugrel identifies a potentially distinct endotype of patients with aspirin-exacerbated respiratory disease.

Authors:  Tanya M Laidlaw; Katherine N Cahill; Juan Carlos Cardet; Katherine Murphy; Jing Cui; Brittney Dioneda; Parul Kothari; Benjamin A Raby; Elliot Israel; Joshua A Boyce
Journal:  J Allergy Clin Immunol       Date:  2018-06-08       Impact factor: 10.793
  10 in total
  2 in total

1.  Objective validity of patient-reported symptoms in aspirin-exacerbated respiratory disease patients.

Authors:  Pooja P Patel; Jing Cui; Katherine N Cahill; Tanya M Laidlaw
Journal:  Clin Exp Allergy       Date:  2021-12-01       Impact factor: 5.018

2.  Mediator production and severity of aspirin-induced respiratory reactions: Impact of sampling site and body mass index.

Authors:  Katherine N Cahill; Pingsheng Wu; Ginger L Milne; Taneem Amin; Joseph Singer; Katherine Murphy; Erin Lewis; Deborah Gapko; Joshua A Boyce; Katherine M Buchheit; Tanya M Laidlaw
Journal:  J Allergy Clin Immunol       Date:  2022-01-11       Impact factor: 14.290
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.